A 2 gtl 1 cDNA library prepared from bovine leukaemia virus (BLV)-producing ovine cells was screened with a cocktail of anti-BLV gp51 monoclonal antibodies (MAbs). Four recombinant phages with inserts of about 2-5 kbp were isolated. One, 2 BLV-gp51-1, was sequenced and shown to encode the C-terminal part of gpS1 and all of gp30. This insert was subcloned into pEV-vrfl and expressed in Escherichia coli N-4830-1 cells. The BLV product and a series of antipeptide antibodies were used to localize the sequential epitopes defined on BLV envelope glycoprotein gp51 by their reactivity with MAbs. Epitope B was localized to amino acids 180 to 205, B' to residues 195 to 205, D and D' to residues 218 to 237, and A to amino acids 249 to 260. All the mapped sequential epitopes were localized in the C-terminal half of BLV gp51. The results of epitope mapping with bacterially produced gp51 confirm the map obtained using native viral glycoprotein.
A 2 gtl 1 cDNA library prepared from bovine leukaemia virus (BLV)-producing ovine cells was screened with a cocktail of anti-BLV gp51 monoclonal antibodies (MAbs). Four recombinant phages with inserts of about 2-5 kbp were isolated. One, 2 BLV-gp51-1, was sequenced and shown to encode the C-terminal part of gpS1 and all of gp30. This insert was subcloned into pEV-vrfl and expressed in Escherichia coli N-4830-1 cells. The BLV product and a series of antipeptide antibodies were used to localize the sequential epitopes defined on BLV envelope glycoprotein gp51 by their reactivity with MAbs. Epitope B was localized to amino acids 180 to 205, B' to residues 195 to 205, D and D' to residues 218 to 237, and A to amino acids 249 to 260. All the mapped sequential epitopes were localized in the C-terminal half of BLV gp51. The results of epitope mapping with bacterially produced gp51 confirm the map obtained using native viral glycoprotein.
Retroviral envelope glycoproteins are known to play a critical role as targets for the host immune responses. Binding of these molecules to specific cell surface receptors is the first event leading to retrovirus infection. Identification and mapping of B cell epitopes on viral glycoproteins have contributed to a better understanding of their three-dimensional (3D) organization and to the definition of important regions likely to be useful for the development of subunit vaccines and diagnostic reagents. In the case of bovine leukaemia virus (BLV), the aetiological agent of enzootic bovine leukosis (Burny et al., 1990) , the molecular dissection of the external glycoprotein, gp51, with a panel of monoclonal antibodies (MAbs) has allowed the definition of eight distinct antigenic sites (A to H) and three overlapping sites (B', D' and F') (Bruck et al., 1982a ; unpublished results for F').
Gp51 carries three conformational epitopes (F, G and H), localized to its amino-terminal part (Portetelle et al., 1989a) . These represent major determinants involved in the biological activities of the virus (infectivity and syncytium induction) (Bruck et al., 1982b) , and are important target epitopes for the serological diagnosis of BLV infection (Portetelle et al., 1989b) . Antibodies directed against these epitopes behave like protective antibodies in BLV vaccination experiments Altaner et al., 1991) .
Attempts to localize these conformational epitopes precisely either by comparisons of the amino acid sequences of BLV variants (Portetelle et al., 1989a; Mamoun et al., 1990) or by the use of synthetic peptides (Portetelle et al., 1989c) have been unsuccessful. However, sequential epitopes A, B, B', D, D' and E have recently been localized to the C-terminal half of native gp51 by using synthetic peptides . In this study, we have designed another strategy to refine the mapping of these sequential epitopes by using a recombinant unglycosylated gp51 polypeptide backbone and a series of antipeptide antibodies.
The prototype BLV variant was grown in chronically infected foetal lamb kidney (FLK) cells; we used a clone (Altaner et al., 1985) derived from the FLK cell line initially established by Van der Maaten & Miller (1976) as a high virus producer. To isolate cDNAs encoding BLV gp51, a 2 gtll cDNA library was constructed according to the method of Young & Davis (1983) .
Recombinant phages were screened for their reactivity with a cocktail of MAbs recognizing sequential epitopes. After incubation for 4 h at 42 °C, nitrocellulose membranes soaked in 10 mM-IPTG were placed on the 0001-0964 © 1992 SGM top of the agar layer, and the plates were incubated at 37 °C for 15 h. The filters were then washed in a solution of TBS buffer (10 mM-Tris-HC1 pH 7.8, 150 mM-NaCI) containing 10~ skimmed milk, and incubated for 2 h at room temperature with MAbs. After washing with TBST buffer (TBS containing 0.5 ~ Tween 20), secondary antimouse immunoglobulins conjugated with alkaline phosphatase (75 ng/ml) were added, and the filters were incubated for 2 h at room temperature. After washing with TBST buffer, plaques were visualized using a mixture of nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate toluidine salt at a 1 : 1 molar ratio as the chromogenic substrate.
Immunoscreening of approximately 5 x 105 recombinant phages yielded four recombinant clones (2 BLVgp51-1, -2, -3 and -4), which were purified further. To confirm the binding specificity of one of these recombinant products to anti-gp51 MAbs, the lysate from lysogenic Y1089 cells infected with 2 BLV-gp51-1 was tested in a Western blot with a mixture of MAbs directed against the BLV gp51 sequential epitopes. A fusion protein, gp51-fl-galactosidase, of about 150K was specifically detected.
To determine which epitopes were expressed on the recombinant product, each phage clone was tested separately with each MAb that recognized a sequential or conformational epitope on native gp51. For all four recombinant phages, a positive immunoreaction was detected only when MAbs directed against sequential epitopes A, B, B', D or D' were used.
The four re¢ombinants isolated have an identical insert of about 2.5 kbp which hybridizes to a BLV envspecific probe (data not shown). To determine precisely the BLV information present in the BLV-gp51-1 recombinant phage, its EcoRI insert was subcloned into pBluescriptlI Sk ÷ and sequenced (data not shown). This cDNA, containing nucleotides 5214 to 7719 of the BLV provirus (Rice et al., 1987) , encodes the C-terminal 101 amino acids of gp51 (residues 167 to 268) and the complete gp30 product (214 amino acids). Expressed in bacteria, it should give an unglycosylated product of about 32K.
To express the BLV-gp51-1 product alone, unfused to fl-galactosidase, the EcoRI c D N A insert was subcloned in pEV-vrfl (Crowl et al., 1985) and expressed in Escherichia coli N-4830-1 (2 ci857) cells. The recombinant plasmid and its product were named pBLV-gp51-1 and Cgp51-gp30, respectively. The bacterial lysate was then tested in a Western blot. A protein of about 32K was detected only when MAbs directed against sequential epitopes A, B, B', D and D' were used (Fig. 1) .
We then took advantage of a panel of synthetic peptides covering almost the entire sequence of gp51 and the corresponding rabbit antipeptide antibodies (Calle- , 1991a, b) . The rabbit antipeptide sera directed against peptides derived from the C-terminal part of gp51 (Table 1) were used to map epitopes on the recombinant Cgp51-gp30 product in the lysate of cells transformed with pBLV-gp51-1. Two experimental approaches based on competitive solid-phase sandwich ELISA were used. In both systems the recombinant Cgp51-gp30 product was linked to a MAb of particular epitope specificity coated on the solid phase. In the first approach, the rabbit antipeptide sera were tested for their ability to bind to the MAb-Cgp51-gp30 complex; the final immune complex was assayed by using anti-rabbit immunoglobulins conjugated with peroxidase. Briefly, each microplate well was coated with 300 ng MAb and Cgp51-gp30 from the bacterial lysate was then adsorbed to the MAbs. After incubation and washing, dilutions of 1 : 1000 of each rabbit antibody were added and the adsorbed rabbit antibodies were finally visualized using a peroxidase-anti-rabbit immunoglobulin conjugate.
It was observed that when the Cgp51-gp30 product was adsorbed with MAb A, the binding of rabbit antipeptide sera R2664 and R91 but not that ofsera R99, R21, R2659, R93 or R2651 was prevented ( Table 2 ). Considering that sera R91, R2664 and R2651 recognize peptides 249 to 268,255 to 268 and 260 to 268, our results led us to map epitope A to the region between amino acids 249 and 260; epitope A was initially mapped to peptide 249 to 268 (Callebaut et al., 1991a) .
In the same way, epitopes D and D' were localized in the region of amino acids 218 to 237 based on the inhibition of binding of rabbit antipeptide 218 to 237 serum (R93) to Cgp51-gp30 pre-adsorbed with MAb D or D'.
Epitope B' was found to map to a narrow region of amino acids defined by the rabbit antipeptide 195 to 205 serum (R2659). In the case of locating epitope B, it appeared that this epitope is defined by a stretch of amino acids encompassing two peptides recognized by the rabbit antipeptide 169 to 188 serum (R21) and the rabbit antipeptide 195 to 205 serum (R2659). No inhibition reaction occurred with rabbit antipeptide 168 to 180 serum (R99). Consequently, epitope B was localized between amino acids 180 and 205, instead of amino acids 195 and 205 (Callebaut et al., 1991a) ; it should be noted that the antipeptide 169 to 188 serum was raised after this previous study and the data suggest steric hindrance between antibodies reacting with the region encompassing amino acids 180 to 205.
In the second approach, immunological reactions were performed in the following order. First, anti-gp51 MAbs with different epitope specificities were coated onto wells and the recombinant Cgp51-gp30 product was added. After overnight incubation at 4°C, rabbit antipeptide serum (dilution 1 : 1000) and MAbs (200 ng) conjugated with peroxidase were tested for their mutual competition for binding to the MAb-Cgp51-gp30 complex. The presence of bound peroxidase-MAb conjugates was revealed by determination of peroxidase activity after addition of the reagents o-phenylenediamine and H202. These data are summarized in Table 3 and are in agreement with those obtained by the first approach. The influence of distance between epitopes was more pronounced in this test; the proximity of epitopes D and D' to epitopes B and B' on one side and epitope A on the other can be deduced from the data. These results also confirm that epitopes B and B' are located very close to each other.
2 gtl 1 libraries have already been used for the epitope mapping of many recombinant unglycosylated products (Wang & Strauss, 1991) . In this study a 2 gt 11 library was used to isolate BLV cDNAs encoding sequential epitopes of BLV gp51. Indeed, the sequential epitopes of gp51 on the hybrid protein expressed in bacteria (the Cterminal portion of gp51 and complete gp30) were successfully determined by competitive ELISA. Apparently the presence of gp30 and the absence of glycosylation did not influence epitope mapping.
The mapping of epitopes on the recombinant Cgp51-gp30 product expressed in bacteria confirmed and refined the mapping achieved with native viral glycoprotein (Portetelle et al., 1989 a; . The absence of the nucleotide sequence encoding epitope E was obviously the reason why this sequential epitope could not be localized. Site-directed mutagenesis of 
